2. Ovarian cancer 2.1. Overview Ovarian cancer is a malignant gynaecological disease, and it is also the seventh most frequent cancer worldwide, with over 240,000 cases diagnosed each year (Yoshida et al. 2020). Ovarian cancer is often not detected until it has progressed to an advanced stag...
BMC Cancer (2022) 22:1150 https://doi.org/10.1186/s12885-022-10191-5 BMC Cancer RESEARCH Open Access Rucaparib in recurrent ovarian cancer: real-world experience from the rucaparib early access programme in Spain – A GEICO study Alfonso Yubero1*, Aranzazu Barquín2, Purificación ...
Ovarian cancer is the second leading cause of gynecologic cancer death worldwide, with only 20% of cases detected early due to its elusive nature, limiting successful treatment. Most deaths occur from the disease progressing to advanced stages. Despite advances in chemo- and immunotherapy, the 5-...
Among gynecological cancers, ovarian cancer (OC) has ranked as the second most frequent cause of death [1]. GLOBOCAN cancer statistics for the year 2020 showed that OC was the eighth most common and fatal cancer diagnosed among women worldwide [2, 3]. Approximately 70% of OC patients were...
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. Article PubMed Google Scholar Cree IA, White VA, Indave BI, Lokuhetty D. Revising the WHO classification: female genital tract ...
Ovarian cancer is the second most common gynecological cancer type after uterine cancers. In 2020, according to worldwide statistics, there were more than 313,000 new cases of ovarian cancer. Most concerning with ovarian cancer is the poor overall survival, with only 30% of patients surviving fo...
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209–249 (2021). Article PubMed Google Scholar Dalmartello, M. et al. European cancer mortality predictions for the year 2022 with focus on ovarian...
The human genome contains regulatory elements, such as enhancers, that are often rewired by cancer cells for the activation of genes that promote tumorigenesis and resistance to therapy. This is especially true for cancers that have little or no known driver mutations within protein coding genes, ...
Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study. Cancers (Basel). 2022;14(9):2230. Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, et al. Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol. 2012;120(3...
Growing prevalence of ovarian cancer The escalating prevalence of ovarian cancer is a primary driver shaping the dynamics of the global ovarian cancer market. Ovarian cancer is one of the most common gynecologic malignancies affecting women worldwide. According to the World Health Organization (WHO),...